mTOR — ìèøåíü ðàïàìèöèíà ó ìëåêîïèòàþùèõ (mammalian target of rapamycin)
NB! — âàæíî, îáðàòèòü âíèìàíèå (nota bene)
NICE — Íàöèîíàëüíûé èíñòèòóò çäîðîâüÿ è êëèíè÷åñêîãî ñîâåðøåíñòâîâàíèÿ (êà÷åñòâà ìåäèöèíñêîé ïîìîùè) Âåëèêîáðèòàíèè (National Institute for Health and Clinical Excellence)
NK — åñòåñòâåííûå êëåòêè-êèëëåðû (natural killer) NMDA — È-ìåòèë-Â-àñïàðòàò (N-methyl-D-aspartate)
NNT — ÷èñëî áîëüíûõ, êîòîðûõ íåîáõîäèìî ïðîëå÷èòü, ÷òîáû äîñòè÷ü êàêîãî-òî óêàçàííîãî ýôôåêòà (number need to treatment)
OR — îòíîøåíèå øàíñîâ (odds ratio)
paCO2 — ïàðöèàëüíîå äàâëåíèå óãëåêèñëîãî ãàçà â àðòåðèàëüíîé êðîâè
PALS — êóðñû ðàñøèðåííûõ ðåàíèìàöèîííûõ ìåðîïðèÿòèé â ïåäèàòðèè (Pediatric Advanced Life Support)
PANDAS — àóòîèììóííîå íåéðîïñèõèàòðè÷åñêîå ðàññòðîéñòâî â äåòñêîì âîçðàñòå, àññîöèèðîâàííîå ñî ñòðåïòîêîêêîâîé èíôåêöèåé (pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection)
 õîäå ïîäãîòîâêè ñòàòåé ïî äèåòîëîãèè â òåðàïèè äëÿ ïîëüçîâàòåëåé ñàéòà ÌåäÓíèâåð èñïîëüçîâàíû òðóäû ñëåäóþùèõ àâòîðîâ:
Hall, K. D. et al. Quantification of the effect of energy imbalance on bodyweight. Lancet 378, 826–837 (2011).
Wishnofsky, M. Caloric equivalents of gained or lost weight. Am. J. Clin. Nutr. 6, 542–546 (1958).
Melby, C. L., Paris, H. L., Foright, R. M. & Peth, J. Attenuating the biologic drive for weight regain following weight loss: Must what goes down always go back up? Nutrients 9, (2017).
Byrne, N. M., Wood, R. E., Schutz, Y. & Hills, A. P. Does metabolic compensation explain the majority of less-than-expected weight loss in obese adults during a short-term severe diet and exercise intervention? Int. J. Obes. 36, 1472–1478 (2012).
Hall, K. D. & Jordan, P. N. Modeling weight-loss maintenance to help prevent body weight regain. Am. J. Clin. Nutr. 88, 1495–1503 (2008).
Javed, F. et al. Brain and high metabolic rate organ mass: Contributions to resting energy expenditure beyond fat-free mass. Am. J. Clin. Nutr. 91, 907–912 (2010).
Thomas, D. M. et al. Effect of dietary adherence on the body weight plateau: A mathematical model incorporating intermittent compliance with energy intake prescription. Am. J. Clin. Nutr. 100, 787–795 (2014).
Sacks, F. M. et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N. Engl. J. Med. 360, 859–873 (2009).
Johnston, B. C. et al. Comparison of weight loss among named diet programs in overweight and obese adults. JAMA 312, 923–923 (2014).
Stubbs, R. J., Ritz, P., Coward, W. A. & Prentice, A. M. Covert manipulation of the ratio of dietary fat to carbohydrate and energy density: Effect on food intake and energy balance in free-living men eating ad libitum. Am. J. Clin. Nutr. 62, 330–337 (1995).
Foster, G. D. et al. A randomized trial of a low-carbohydrate diet for obesity. N. Engl. J. Med. 348, 2082–2090 (2003).
Dansinger, M. L., Gleason, J. A., Griffith, J. L., Selker, H. P. & Schaefer, E. J. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: A randomized trial. JAMA 293, 43–53 (2005).
Samaha, F. F. et al. A low-carbohydrate as compared with a low-fat diet in severe obesity. N. Engl. J.Med. 348, 2074–2081 (2003).
Stern, L. et al. The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: One-year follow-up of a randomized trial. Ann. Intern. Med. 140, 778–785 (2004).
Astrup, A. et al. The role of dietary fat in body fatness: Evidence from a preliminary meta-analysis of ad libitum low-fat dietary intervention studies. Br. J. Nutr. 83 Suppl 1, S25–32 (2000).
Thomas, C. D. et al. Nutrient balance and energy expenditure during ad libitum feeding of high-fat and high-carbohydrate diets in humans. Am. J. Clin. Nutr. 55, 934–942 (1992).
Krieger, J. W., Sitren, H. S., Daniels, M. J. & Langkamp-Henken, B. Effects of variation in protein and carbohydrate intake on body mass and composition during energy restriction: A meta-regression 1. Am.J.Clin. Nutr. 83, 260–274 (2006).
Wycherley, T. P., Moran, L. J., Clifton, P. M., Noakes, M. & Brinkworth, G. D. Effects of energyrestricted high-protein, low-fat compared with standard-protein, low-fat diets: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 96, 1281–1298 (2012).
Lejeune, M. P. G. M., Westerterp, K. R., Adam, T. C. M., Luscombe-Marsh, N. D. & Westerterp-Plantenga, M. S. Ghrelin and glucagon-like peptide 1 concentrations, 24-h satiety, and energy and substrate metabolism during a high-protein diet and measured in a respiration chamber. Am. J. Clin. Nutr. 83, 89–94 (2006).
Stock, M. J. Gluttony and thermogenesis revisited. Int. J. Obes. Relat. Metab. Disord. J. Int. Assoc. Study Obes. 23, 1105–1117 (1999).
Schwingshackl, L. & Hoffmann, G. Long-term effects of low-fat diets either low or high in protein on cardiovascular and metabolic risk factors: A systematic review and meta-analysis. Nutr. J. 12, 48 (2013).
Lepe, M., Bacardi Gascon, M. & Jimenez Cruz, A. Long-term efficacy of high-protein diets: A systematic review. Nutr. Hosp. 26, 1256–1259 (2011).
Clifton, P. M., Condo, D. & Keogh, J. B. Long term weight maintenance after advice to consume low carbohydrate, higher protein diets—a systematic review and meta analysis. Nutr. Metab. Cardiovasc. Dis. NMCD 24, 224–235 (2014).
Kjolbak, L. et al. Protein supplements after weight loss do not improve weight maintenance compared with recommended dietary protein intake despite beneficial effects on appetite sensation and energy expenditure: A randomized, controlled, double-blinded trial. Am. J. Clin. Nutr. 106, 684–697 (2017).
Pi-Sunyer, F. X. Glycemic index and disease. Am. J. Clin. Nutr. 76, 290S–8S (2002).
Ludwig, D. S. Dietary glycemic index and obesity. J. Nutr. 130, 280S–283S (2000).
Roberts, S. B. High-glycemic index foods, hunger, and obesity: Is there a connection? Nutr. Rev. 58, 163–169 (2000).
Larsen, T. M. et al. Diets with high or low protein content and glycemic index for weight-loss maintenance. N. Engl. J. Med. 363, 2102–2113 (2010).
Thomas, D. E., Elliott, E. J. & Baur, L. Low glycaemic index or low glycaemic load diets for overweight and obesity. Cochrane Database Syst. Rev. CD005105-CD005105 (2007). doi:10.1002/14651858. CD005105.pub2.
Esfahani, A., Wong, J. M. W., Mirrahimi, A., Villa, C. R. & Kendall, C. W. C. The application of the glycemic index and glycemic load in weight loss: A review of the clinical evidence. IUBMB Life 63, 7–13 (2011).
Ajala, O., English, P. & Pinkney, J. Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am. J. Clin. Nutr. 97, 505–516 (2013).
McMillan-Price, J. et al. Comparison of 4 diets of varying glycemic load on weight loss and cardiovascular risk reduction in overweight and obese young adults: A randomized controlled trial. Arch. Intern. Med. 166, 1466–1475 (2006).
Jonsson, T. et al. A Paleolithic diet confers higher insulin sensitivity, lower C-reactive protein and lower blood pressure than a cereal-based diet in domestic pigs. Nutr. Metab. Lond. 3, 39–39 (2006).
Cussler, E. C. et al. Maintenance of weight loss in overweight middle-aged women through the Internet. Obes. Silver Spring Md 16, 1052–1060 (2008).
Itoh, K. et al. Association between blood pressure and insulin resistance in obese females during weight loss and weight rebound phenomenon. Hypertens. Res. Off. J. Jpn. Soc. Hypertens. 24, 481–487 (2001).
Kuller, L. H. et al. The women on the move through activity and nutrition (WOMAN) study: Final 48-month results. Obes. Silver Spring Md 20, 636–643 (2012).
Layman, D. K. et al. A moderate-protein diet produces sustained weight loss and long-term changes in body composition and blood lipids in obese adults. J. Nutr. 1–8 (2009). doi:10.3945/jn.108.099440. highly.
Thorpe, M. P. et al. A diet high in protein, dairy, and calcium attenuates bone loss over twelve months of weight loss and maintenance relative to a conventional high-carbohydrate diet in adults. J. Nutr. 138, 1096–1100 (2008).
Yankura, D. J. et al. Weight regain and health-related quality of life in postmenopausal women. Obes. Silver Spring Md 16, 2259–2265 (2008).
Ramage, S., Farmer, A., Eccles, K. A. & McCargar, L. Healthy strategies for successful weight loss and weight maintenance: A systematic review. Appl. Physiol. Nutr. Metab. Physiol. Appl. Nutr. Metab. 39, 1–20 (2014).
Phelan, S., Wyatt, H. R., Hill, J. O. & Wing, R. R. Are the eating and exercise habits of successful weight losers changing? Obes. Silver Spring Md 14, 710–716 (2006).
Langlois, K., Garriguet, D. & Findlay, L. Diet composition and obesity among Canadian adults. Health Rep. 20, 11–20 (2009).
Onakpoya, I. J. & Heneghan, C. J. Effect of the novel functional fibre, polyglycoplex (PGX), on body weight and metabolic parameters: A systematic review of randomized clinical trials. Clin. Nutr. Edinb. Scotl. 34, 1109–1114 (2015).
Kacinik, V. et al. Effect of PGX, a novel functional fibre supplement, on subjective ratings of appetite in overweight and obese women consuming a 3-day structured, low-calorie diet. Nutr. Diabetes 1, e22 (2011).
Reimer, R. A. et al. Increased plasma PYY levels following supplementation with the functional fiber PolyGlycopleX in healthy adults. Eur. J. Clin. Nutr. 64, 1186–1191 (2010).
Reimer, R. A. et al. Changes in visceral adiposity and serum cholesterol with a novel viscous polysaccharide in Japanese adults with abdominal obesity. Obes. Silver Spring Md 21, E379–387 (2013).
Kim, S. J. et al. Effects of dietary pulse consumption on body weight: A systematic review and metaanalysis of randomized controlled trials. Am. J. Clin. Nutr. 103, 1213–1223 (2016).
Li, S. S. et al. Dietary pulses, satiety and food intake: A systematic review and meta-analysis of acute feeding trials. Obes. Silver Spring Md 22, 1773–1780 (2014).
Higgins, J. A. Resistant starch and energy balance: Impact on weight loss and maintenance. Crit. Rev. Food Sci. Nutr. 54, 1158–1166 (2014).
Higgins, J. A. Resistant starch: Metabolic effects and potential health benefits. J. AOAC Int. 87, 761–768 (2004).
de Roos, N., Heijnen, M. L., de Graaf, C., Woestenenk, G. & Hobbel, E. Resistant starch has little effect on appetite, food intake and insulin secretion of healthy young men. Eur. J. Clin. Nutr. 49, 532–541 (1995).
Robertson, M. D., Bickerton, A. S., Dennis, A. L., Vidal, H. & Frayn, K. N. Insulin-sensitizing effects of dietary resistant starch and effects on skeletal muscle and adipose tissue metabolism. Am. J. Clin. Nutr. 82, 559–567 (2005).
Johnston, K. L., Thomas, E. L., Bell, J. D., Frost, G. S. & Robertson, M. D. Resistant starch improves insulin sensitivity in metabolic syndrome. Diabet. Med. J. Br. Diabet. Assoc. 27, 391–397 (2010).
Bodinham, C. L., Frost, G. S. & Robertson, M. D. Acute ingestion of resistant starch reduces food intake in healthy adults. Br. J. Nutr. 103, 917–922 (2010).
Keogh, J. B., Lau, C. W. H., Noakes, M., Bowen, J. & Clifton, P. M. Effects of meals with high soluble fibre, high amylose barley variant on glucose, insulin, satiety and thermic effect of food in healthy lean women. Eur. J. Clin. Nutr. 61, 597–604 (2007).
Sands, A. L., Leidy, H. J., Hamaker, B. R., Maguire, P. & Campbell, W. W. Consumption of the slowdigesting waxy maize starch leads to blunted plasma glucose and insulin response but does not influence energy expenditure or appetite in humans. Nutr. Res. N. Y. N 29, 383–390 (2009).
Zhang, L. et al. Effect of dietary resistant starch on prevention and treatment of obesity-related diseases and its possible mechanisms. Biomed. Environ. Sci. BES 28, 291–297 (2015).
Stubbs, R. J., Harbron, C. G., Murgatroyd, P. R. & Prentice, A. M. Covert manipulation of dietary fat and energy density: Effect on substrate flux and food intake in men eating ad libitum. Am. J. Clin. Nutr. 62, 316–329 (1995).
Kral, T. V., Roe, L. S. & Rolls, B. J. Combined effects of energy density and portion size on energy intake in women. Am. J. Clin. Nutr. 79, 962–968 (2004).
Rolls, B. J., Bell, E. A. & Thorwart, M. L. Water incorporated into a food but not served with a food decreases energy intake in lean women. Am. J. Clin. Nutr. 70, 448–455 (1999).
Rolls, B. J., Roe, L. S. & Meengs, J. S. Salad and satiety: Energy density and portion size of a first-course salad affect energy intake at lunch. J. Am. Diet. Assoc. 104, 1570–1576 (2004).
Bell, E. A. & Rolls, B. J. Energy density of foods affects energy intake across multiple levels of fat content in lean and obese women. Am. J. Clin. Nutr. 73, 1010–1018 (2001).
Bell, E. A., Castellanos, V. H., Pelkman, C. L., Thorwart, M. L. & Rolls, B. J. Energy density of foods affects energy intake in normal-weight women. Am. J. Clin. Nutr. 67, 412–420 (1998).
Rolls, B. J., Roe, L. S., Beach, A. M. & Kris-Etherton, P. M. Provision of foods differing in energy density affects long-term weight loss. Obes. Res. 13, 1052–1060 (2005).
Ello-Martin, J. A., Roe, L. S., Ledikwe, J. H., Beach, A. M. & Rolls, B. J. Dietary energy density in the treatment of obesity: A year-long trial comparing 2 weight-loss diets. Am. J. Clin. Nutr. 85, 1465–1477 (2007).
Raynor, H. A., Looney, S. M., Steeves, E. A., Spence, M. & Gorin, A. A. The effects of an energy density prescription on diet quality and weight loss: A pilot randomized controlled trial. J. Acad. Nutr. Diet. 112, 1397–1402 (2012).
Lowe, M. R., Butryn, M. L., Thomas, J. G. & Coletta, M. Meal replacements, reduced energy density eating, and weight loss maintenance in primary care patients: A randomized controlled trial. Obes. Silver Spring 22, 94–100 (2014).
Kennedy, E. T., Bowman, S. A., Spence, J. T., Freedman, M. & King, J. Popular diets: Correlation to health, nutrition, and obesity. J. Am. Diet. Assoc. 101, 411–420 (2001).
Newby, P. K., Tucker, K. L. & Wolk, A. Risk of overweight and obesity among semivegetarian, lactovegetarian, and vegan women. Am. J. Clin. Nutr. 81, 1267–1274 (2005).
Spencer, E. A., Appleby, P. N., Davey, G. K. & Key, T. J. Diet and body mass index in 38000 EPIC-Oxford meat-eaters, fish-eaters, vegetarians and vegans. Int. J. Obes. Relat. Metab. Disord. 27, 728–734 (2003).
Howarth, N. C., Saltzman, E. & Roberts, S. B. Dietary fiber and weight regulation. Nutr. Rev. 59, 129–139 (2001).
Burke, L. E. et al. A randomized clinical trial of a standard versus vegetarian diet for weight loss: The impact of treatment preference. Int. J. Obes. 2005 32, 166–176 (2008).
Turner-McGrievy, G. M., Barnard, N. D. & Scialli, A. R. A two-year randomized weight loss trial comparing a vegan diet to a more moderate low-fat diet. Obes. Silver Spring 15, 2276–2281 (2007).
Turner-McGrievy, G. M., Davidson, C. R., Wingard, E. E., Wilcox, S. & Frongillo, E. A. Comparative effectiveness of plant-based diets for weight loss: A randomized controlled trial of five different diets. Nutrition 31, 350–358 (2015).
Goulet, J., Lamarche, B., Nadeau, G. & Lemieux, S. Effect of a nutritional intervention promoting the Mediterranean food pattern on plasma lipids, lipoproteins and body weight in healthy French-Canadian women. Atherosclerosis 170, 115–124 (2003).
Andreoli, A. et al. Effect of a moderately hypoenergetic Mediterranean diet and exercise program on body cell mass and cardiovascular risk factors in obese women. Eur. J. Clin. Nutr. 62, 892–897 (2008).
Beunza, J. J. et al. Adherence to the Mediterranean diet, long-term weight change, and incident overweight or obesity: The Seguimiento Universidad de Navarra (SUN) cohort. Am. J. Clin. Nutr. 92, 1484–1493 (2010).
Martinez-Gonzalez, M. A. et al. A 14-item Mediterranean diet assessment tool and obesity indexes among high-risk subjects: The PREDIMED trial. PLoS One 7, e43134–e43134 (2012).
Romaguera, D. et al. Mediterranean dietary patterns and prospective weight change in participants of the EPIC-PANACEA project. Am. J. Clin. Nutr. 92, 912–921 (2010).
Mendez, M. A. et al. Adherence to a Mediterranean diet is associated with reduced 3-year incidence of obesity. J. Nutr. 136, 2934–2938 (2006).
Garcia-Fernandez, E., Rico-Cabanas, L., Rosgaard, N., Estruch, R. & Bach-Faig, A. Mediterranean diet and cardiodiabesity: A review. Nutrients 6, 3474–3500 (2014).
Mozaffarian, D., Hao, T., Rimm, E. B., Willett, W. C. & Hu, F. B. Changes in diet and lifestyle and longterm weight gain in women and men. N. Engl. J. Med. 364, 2392–2404 (2011).
Good, C. K., Holschuh, N., Albertson, A. M. & Eldridge, A. L. Whole grain consumption and body mass index in adult women: An analysis of NHANES 1999-2000 and the USDA pyramid servings database. J. Am. Coll. Nutr. 27, 80–87 (2008).
Jonsson, T. et al. Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: A randomized cross-over pilot study. Cardiovasc. Diabetol. 8, 35–35 (2009).
Lindeberg, S. et al. A Palaeolithic diet improves glucose tolerance more than a Mediterranean-like diet in individuals with ischaemic heart disease. Diabetologia 50, 1795–1807 (2007).
Howlett, J. & Ashwell, M. Glycemic response and health: Summary of a workshop. Am. J. Clin. Nutr. 87, 212S–216S (2008).
Livesey, G., Taylor, R., Hulshof, T. & Howlett, J. Glycemic response and health—a systematic review and meta-analysis: Relations between dietary glycemic properties and health outcomes. Am. J. Clin. Nutr. 87, 258S–268S (2008).
Riccardi, G., Rivellese, A. A. & Giacco, R. Role of glycemic index and glycemic load in the healthy state, in prediabetes, and in diabetes. Am. J. Clin. Nutr. 87, 269S–274S (2008).
Thomas, D. & Elliott, E. J. Low glycaemic index, or low glycaemic load, diets for diabetes mellitus. Cochrane Database Syst. Rev. CD006296-CD006296 (2009). doi:10.1002/14651858.CD006296.pub2.
Osterdahl, M., Kocturk, T., Koochek, A. & Wandell, P. E. Effects of a short-term intervention with a paleolithic diet in healthy volunteers. Eur. J. Clin. Nutr. 62, 682–685 (2008).
Frassetto, L. A., Schloetter, M., Mietus-Synder, M., Morris Jr., R. C. & Sebastian, A. Metabolic and physiologic improvements from consuming a paleolithic, hunter-gatherer type diet. Eur. J. Clin. Nutr.
Jonsson, T. et al. Subjective satiety and other experiences of a Paleolithic diet compared to a diabetes diet in patients with type 2 diabetes. Nutr. J. 12, 105–105 (2013).
Boers, I. et al. Favourable effects of consuming a Palaeolithic-type diet on characteristics of the metabolic syndrome: A randomized controlled pilot-study. Lipids Health Dis. 13, 160–160 (2014).
Rolls, B. J., Morris, E. L. & Roe, L. S. Portion size of food affects energy intake in normal-weight and overweight men and women. Am. J. Clin. Nutr. 76, 1207–1213 (2002).
Rolls, B. J., Roe, L. S., Meengs, J. S. & Wall, D. E. Increasing the portion size of a sandwich increases energy intake. J. Am. Diet. Assoc. 104, 367–372 (2004).
Rolls, B. J., Roe, L. S. & Meengs, J. S. Larger portion sizes lead to a sustained increase in energy intake over 2 days. J. Am. Diet. Assoc. 106, 543–549 (2006).
Tieken, S. M. et al. Effects of solid versus liquid meal-replacement products of similar energy content on hunger, satiety, and appetite-regulating hormones in older adults. Horm. Metab. Res. 39, 389–394 (2007).
Stull, A. J., Apolzan, J. W., Thalacker-Mercer, A. E., Iglay, H. B. & Campbell, W. W. Liquid and solid meal replacement products differentially affect postprandial appetite and food intake in older adults. J. Am. Diet. Assoc. 108, 1226–1230 (2008).
Miller, G. D. Improved nutrient intake in older obese adults undergoing a structured diet and exercise intentional weight loss program. J. Nutr. Health Aging 14, 461–466 (2010).
Wadden, T. A. et al. One-year weight losses in the Look AHEAD study: Factors associated with success. Obes. Silver Spring 17, 713–722 (2009).
Ryan, D. H. et al. Look AHEAD (Action for Health in Diabetes): Design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin. Trials 24, 610–628 (2003).
Messier, S. P. et al. The intensive diet and exercise for arthritis (IDEA) trial: Design and rationale. BMC. Musculoskelet. Disord. 10, 93–93 (2009).
Hartmann-Boyce, J. et al. Behavioural weight management programmes for adults assessed by trials conducted in everyday contexts: Systematic review and meta-analysis. Obes. Rev. 15, 920–932 (2014).
Rock, C. L. et al. Effect of a free prepared meal and incentivized weight loss program on weight loss and weight loss maintenance in obese and overweight women: A randomized controlled trial. JAMA J. Am. Med. Assoc. 304, 1803–1810 (2010).
Foster, G. D. et al. A randomized comparison of a commercially available portion-controlled weightloss intervention with a diabetes self-management education program. Nutr. Diabetes 3, e63–e63 (2013).
Cheskin, L. J. et al. Efficacy of meal replacements versus a standard food-based diet for weight loss in type 2 diabetes: A controlled clinical trial. Diabetes Educ. 34, 118–127 (2008).
Burgess, E., Hassmen, P., Welvaert, M. & Pumpa, K. L. Behavioural treatment strategies improve adherence to lifestyle intervention programmes in adults with obesity: A systematic review and meta-analysis. Clin. Obes. 7, 105–114 (2017).
Ayyad, C. & Andersen, T. Long-term efficacy of dietary treatment of obesity: A systematic review of studies published between 1931 and 1999. Obes. Rev. Off. J. Int. Assoc. Study Obes. 1, 113–119 (2000).
National Institute of Health, N. H. L. and B. I. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults - the evidence report. Obes. Res. 6, 51S–209S (1998).
Chaston, T. B., Dixon, J. B. & O’Brien, P. E. Changes in fat-free mass during significant weight loss: A systematic review. Int. J. Obes. 2005 31, 743–750 (2007).
Valtuena, S., Blanch, S., Barenys, M., Sola, R. & Salas-Salvado, J. Changes in body composition and resting energy expenditure after rapid weight loss: Is there an energy-metabolism adaptation in obese patients? Int. J. Obes. Relat. Metab. Disord. J. Int. Assoc. Study Obes. 19, 119–125 (1995).
Wadden, T. A., Foster, G. D. & Letizia, K. A. One-year behavioral treatment of obesity: Comparison of moderate and severe caloric restriction and the effects of weight maintenance therapy. J. Consult. Clin. Psychol. 62, 165–171 (1994).
Purcell, K. et al. The effect of rate of weight loss on long-term weight management: A randomised controlled trial. LANCET Diabetes Endocrinol. 8587, 1–9 (2014).
Vink, R. G., Roumans, N. J. T., Arkenbosch, L. A. J., Mariman, E. C. M. & van Baak, M. A. The effect of rate of weight loss on long-term weight regain in adults with overweight and obesity. Obes. Silver Spring Md 24, 321–327 (2016).
Coutinho, S. R. et al. The impact of rate of weight loss on body composition and compensatory mechanisms during weight reduction: A randomized control trial. Clin. Nutr. Edinb. Scotl. (2017). doi:10.1016/j.clnu.2017.04.008.
Eshghinia, S. & Mohammadzadeh, F. The effects of modified alternate-day fasting diet on weight loss and CAD risk factors in overweight and obese women. J. Diabetes Metab. Disord. 12, 4–4 (2013).
Varady, K. A., Bhutani, S., Church, E. C. & Klempel, M. C. Short-term modified alternate-day fasting: A novel dietary strategy for weight loss and cardioprotection in obese adults. Am. J. Clin. Nutr. 90, 1138–1143 (2009).
Hoddy, K. K. et al. Meal timing during alternate day fasting: Impact on body weight and cardiovascular disease risk in obese adults. Obes. Silver Spring 22, 2524–2531 (2014).
Bhutani, S., Klempel, M. C., Kroeger, C. M., Trepanowski, J. F. & Varady, K. A. Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans. Obes. Silver Spring Md 21, 1370–1379 (2013).
Johnson, J. B. et al. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic. Biol. Med. 42, 665–674 (2007).
Patterson, R. E. & Sears, D. D. Metabolic effects of intermittent fasting. Annu. Rev. Nutr. 37, 371–393 (2017).
LeCheminant, J. D., Christenson, E., Bailey, B. W. & Tucker, L. A. Restricting night-time eating reduces daily energy intake in healthy young men: A short-term cross-over study. Br. J. Nutr. 110, 2108–2113 (2013).
Stote, K. S. et al. A controlled trial of reduced meal frequency without caloric restriction in healthy, normal-weight, middle-aged adults. Am. J. Clin. Nutr. 85, 981–988 (2007).
Carlson, O. et al. Impact of reduced meal frequency without caloric restriction on glucose regulation in healthy, normal-weight middle-aged men and women. Metabolism. 56, 1729–1734 (2007).
Chowdhury, E. A. et al. The causal role of breakfast in energy balance and health: A randomized controlled trial in obese adults. Am. J. Clin. Nutr. 103, 747–756 (2016).
Chowdhury, E. A., Richardson, J. D., Tsintzas, K., Thompson, D. & Betts, J. A. Effect of extended morning fasting upon ad libitum lunch intake and associated metabolic and hormonal responses in obese adults. Int. J. Obes. 2005 40, 305–311 (2016).
Healy, G. N. et al. Breaks in sedentary time: Beneficial associations with metabolic risk. Diabetes Care 31, 661–666 (2008).
Booth, F. W., Gordon, S. E., Carlson, C. J. & Hamilton, M. T. Waging war on modern chronic diseases: Primary prevention through exercise biology. J. Appl. Physiol. 1985 88, 774–787 (2000).
Hamilton, M. T., Hamilton, D. G. & Zderic, T. W. Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes 56, 2655–2667 (2007).
Saris, W. H. et al. How much physical activity is enough to prevent unhealthy weight gain? Outcome of the IASO 1st Stock Conference and consensus statement. Obes. Rev. 4, 101–114 (2003).
Haskell, W. L. et al. Physical activity and public health: Updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Med. Sci. Sports Exerc. JID - 8005433 39, 1423–1434 (2007).
Report of the Dietary Guidelines Advisory Committee on the Dietary Guidelines for Americans, 2010. (2010).
Pate, R. R. et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 273, 402–407 (1995).
Donnelly, J. E. et al. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med. Sci. Sports Exerc. 41, 459–471 (2009).
Klem, M. L., Wing, R. R., McGuire, M. T., Seagle, H. M. & Hill, J. O. A descriptive study of individuals successful at long-term maintenance of substantial weight loss. Am. J. Clin. Nutr. 66, 239–246 (1997).
Schoeller, D. A., Shay, K. & Kushner, R. F. How much physical activity is needed to minimize weight gain in previously obese women? Am. J. Clin. Nutr. 66, 551–556 (1997).
Herman, K. M., Carver, T. E., Christou, N. V. & Andersen, R. E. Physical activity and sitting time in bariatric surgery patients 1-16 years post-surgery. Clin. Obes. 4, 267–276 (2014).
Jakicic, J. M., Marcus, B. H., Lang, W. & Janney, C. Effect of exercise on 24-month weight loss maintenance in overweight women. Arch. Intern. Med. 168, 1550–1559; discussion 1559–1560 (2008).
Ross, R., Hudson, R., Stotz, P. J. & Lam, M. Effects of exercise amount and intensity on abdominal obesity and glucose tolerance in obese adults. Ann. Intern. Med. 162, 325–325 (2015).
Reichkendler, M. H. et al. Only minor additional metabolic health benefits of high as opposed to moderate dose physical exercise in young, moderately overweight men. Obesity 22, 1220–1232 (2014).
Tate, D. F., Jeffery, R. W., Sherwood, N. E. & Wing, R. R. Long-term weight losses associated with prescription of higher physical activity goals. Are higher levels of physical activity protective against weight regain? Am. J. Clin. Nutr. 85, 954–959 (2007).
Fogelholm, M., Kujala, U., Kaprio, J. & Sarna, S. Predictors of weight change in middle-aged and old men. Obes. Res. 8, 367–373 (2000).
Perri, M. G. et al. Effects of four maintenance programs on the long-term management of obesity. J. Consult. Clin. Psychol. 56, 529–534 (1988).
Jakicic, J. M., Marcus, B. H., Gallagher, K. I., Napolitano, M. & Lang, W. Effect of exercise duration and intensity on weight loss in overweight, sedentary women: A randomized trial. JAMA 290, 1323–1330 (2003).
Jakicic, J. M., Winters, C. & Wing, R. R. Effects of intermittent exercise and on adherence, weight loss, and fitness in overweight women. October 02906, 1554–1560 (1999).
Jeffery, R. W., Wing, R. R., Sherwood, N. E. & Tate, D. F. Physical activity and weight loss: Does prescribing higher physical activity goals improve outcome? Am. J. Clin. Nutr. 78, 684–689 (2003).
Ewbank, P. P., Darga, L. L. & Lucas, C. P. Physical activity as a predictor of weight maintenance in previously obese subjects. Obes. Res. 3, 257–263 (1995).
Drenowatz, C., Hill, J. O., Peters, J. C., Soriano-Maldonado, A. & Blair, S. N. The association of change in physical activity and body weight in the regulation of total energy expenditure. Eur. J. Clin. Nutr. 71, 377–382 (2017).
Willis, L. H. et al. Effects of aerobic and/or resistance training on body mass and fat mass in overweight or obese adults. J. Appl. Physiol. 1985 113, 1831–1837 (2012).
Davidson, L. E. et al. Effects of exercise modality on insulin resistance and functional limitation in older adults: A randomized controlled trial. Arch. Intern. Med. 169, 122–131 (2009).
Jakicic, J. M. et al. Time-based physical activity interventions for weight loss: A randomized trial. Med. Sci. Sports Exerc. 47, 1061–1069 (2015).
Rees K, Takeda A, Martin N, et al. Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2019; 3: CD009825.
Druesne-Pecollo N, Latino-Martel P, Norat T, et al. Beta-carotene supplementation and cancer risk: a systematic review and metaanalysis of randomized controlled trials. Int J Cancer. 2010; 127: 172–184.
Estruch R, Ros E, Salas-Salvad? J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2018; 378: e34.1–e34.14.
Wang L, Sesso HD, Glynn RJ, et al. Vitamin E and C supplementation and risk of cancer in men: posttrial follow-up in the Physicians’ Health Study II randomized trial. Am J Clin Nutr. 2014; 100: 915–923.
Vollset SE, Clarke R, Lewington S, et al. Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet. 2013; 381: 1029–1036.
Vinceti M, Filippini T, Del Giovane C, et al. Selenium for preventing cancer. Cochrane Database Syst Rev. 2018; 1: CD005195.
Yao Y, Suo T, Andersson R, et al. Dietary fibre for the prevention of recurrent colorectal adenomas and carcinomas. Cochrane Database Syst Rev. 2017; 1: CD003430.
Saneei P, Salehi-Abargouei A, Esmaillzadeh A, et al. Influence of dietary approaches to stop hypertension (DASH) diet on blood pressure: a systematic review and meta-analysis on randomized controlled trials. Nutr Metab Cardiovasc Dis. 2014; 24: 1253–1261.
Ajala O, English P, Pinkney J. Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr. 2013; 97: 505–516.
Bjelakovic G, Nikolova D, Gluud LL, et al. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. 2012; 3: CD007176.
Manson JE, Cook NR, Lee IM, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019; 380: 33–44.
Manson JE, Cook NR, Lee IM, et al. Marine n-3 fatty acids and prevention of cardiovascular disease and cancer. N Engl J Med. 2019; 380: 23–32.
Writing group for the AREDS2 research group. Effect of long-chain ?-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA Intern Med. 2014; 174: 763–771.
Swinburn BA, Kraak VI, Allender S, et al. The global syndemic of obesity, undernutrition, and climate change: the Lancet Commission report. Lancet. 2019; 393: 791–846.
Kochanek KD, Murphy SL, Xu J, et al. National vital statistics reports, deaths: final data for 2017. Natl Vital Stat Rep. 2019; 68: 1–77.
Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation. 2016; 133: 187–225.
Sotos-Prieto M, Bhupathiraju SN, Mattei J, et al. Association of changes in diet quality with total and cause-specific mortality. N Engl J Med. 2017; 377: 143–153.
Miller V, Mente A, Dehghan M, et al. Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study. Lancet. 2017; 390: 2037–2049.
Zong G, Gao A, Hu F, et al. Whole grain intake and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis of prospective cohort studies. Circulation. 2016; 133: 2370–2380.
Mattioli AV, Palmiero P, Manfrini O, et al. Mediterranean diet impact on cardiovascular diseases: a narrative review. J Cardiovasc Med (Hagerstown). 2017; 18: 925–935.
Mayhew AJ, de Souza RJ, Meyre D, et al. A systematic review and meta-analysis of nut consumption and incident risk of CVD and all-cause mortality. Br J Nutr. 2016; 115: 212–225.
Keskin M, Ipek G, Aldag M, et al. Effect of nutritional status on mortality in patients undergoing coronary artery bypass grafting. Nutrition. 2018; 48: 82–86.
van den Brandt PA. Red meat, processed meat, and other dietary protein sources and risk of overall and cause-specific mortality in the Netherlands Cohort Study. Eur J Epidemiol. 2019; 34: 351–369.
World Cancer Research Fund. http://www.wcrf.org/. Accessed March 25, 2019.
Bouvard V, Loomis D, Guyton KZ, et al. Carcinogenicity of consumption of red and processed meat. Lancet Oncol. 2015; 16: 1599–1600.
Thanikachalam K, Khan G. Colorectal cancer and nutrition. Nutrients. 2019; 1–11.
Morris MC, Tangney CC, Wang Y, et al. MIND diet associated with reduced incidence of Alzheimer’s disease. Alzheimers Dement. 2015; 11: 1007–1014.
U.S. Preventive Services Taskforce. Folic acid supplementation for the prevention of neural tube defects. US Preventive Services Task Force recommendation statement. JAMA. 2017; 317: 183–189.
GBD 2017 Diet Collaborators. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019; 393: 1958–1972.
Patnode CD, Evans CV, Senger CA, et al. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults without known cardiovascular disease risk factors: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2017; 318: 175–193.
Millen BE, Abrams S, Adams-Campbell L, et al. The 2015 Dietary Guidelines Advisory Committee scientific report: development and major conclusions. Adv Nutr. 2016; 7: 438–444.
Grossman DC, Bibbins-Domingo K, Curry SJ, et al. Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults without cardiovascular risk factors: US Preventive Services Task Force Recommendation Statement. JAMA. 2017; 318: 167–174.
Trehan I, Goldbach HS, LaGrone LN, et al. Antibiotics as part of the management of severe acute malnutrition. N Engl J Med. 2013; 368: 425–435.
Isanaka S, Langendorf C, Berth? F, et al. Routine amoxicillin for uncomplicated severe acute malnutrition in children. N Engl J Med. 2016; 374: 444–453.
Bally MR, Blaser Yildirim PZ, Bounoure L, et al. Nutritional support and outcomes in malnourished medical inpatients: a systematic review and meta-analysis. JAMA Intern Med. 2016; 176: 43–53.
Iannotti LL, Lutter CK, Stewart CP, et al. Eggs in early complementary feeding and child growth: a randomized controlled trial. Pediatrics. 2017; 140: 1–8.
Bhutta ZA, Berkley JA, Bandsma RHJ, et al. Severe childhood malnutrition. Nat Rev Dis Primers. 2017; 3: 1–18.
Swinburn BA, Kraak VI, Allender S, et al. The global syndemic of obesity, undernutrition, and climate change: the Lancet Commission report. Lancet. 2019; 393: 791–846.
United Nations Children’s Fund (UNICEF), World Health Organization (WHO), World Bank Group. Levels and Trends in Child Malnutrition. New York: UNICEF, WHO, World Bank Group; 2017.
Papathakis PC, Singh LN, Manary MJ. How maternal malnutrition affects linear growth and development in the offspring. Mol Cell Endocrinol. 2016; 435: 40–47.
Owino VO, Murphy-Alford AJ, Kerac M, et al. Measuring growth and medium- and longer-term outcomes in malnourished children. Matern Child Nutr. 2019; 15: 1–10.
Trehan I, Kelly P, Shaikh N, et al. New insights into environmental enteric dysfunction. Arch Dis Child. 2016; 101: 741–744.
Velly H, Britton RA, Preidis GA. Mechanisms of cross-talk between the diet, the intestinal microbiome, and the undernourished host. Gut Microbes. 2017; 8: 98–112.
Sadeghi M, Keshavarz-Fathi M, Baracos V, et al. Cancer cachexia: diagnosis, assessment, and treatment. Crit Rev Oncol Hematol. 2018; 127: 91–104.
Di Giovanni V, Bourdon C, Wang DX, et al. Metabolomic changes in serum of children with different clinical diagnoses of malnutrition. J Nutr. 2016; 146: 2436–2444.
Trehan I, Manary MJ. Management of severe acute malnutrition in low-income and middle-income countries. Arch Dis Child. 2015; 100: 283–287.
Coulthard MG. Oedema in kwashiorkor is caused by hypoalbuminaemia. Paediatr Int Child Health. 2015; 35: 83–89.
Chawla A, Francis D, Daniel S, et al. Kwashiorkor in upper middle class suburbia in the United States (FS17-02-19). Curr Dev Nutr. 2019; 3 (Suppl 1): 1137.
Teigen LM, Kuchnia AJ, Nagel EM, et al. Diagnosing clinical malnutrition: perspectives from the past and implications for the future. Clin Nutr ESPEN. 2018; 26: 13–20.
World Health Organization (WHO), United Nations Children’s Fund (UNICEF). Guideline: updates on HIV and infant feeding: the duration of breastfeeding, and support from health services to improve feeding practices among mothers living with HIV. Geneva: WHO, UNICEF, 2016.
Ridley E, Gantner D, Pellegrino V, et al. Nutrition therapy in critically ill patients — a review of current evidence for clinicians. Clin Nutr. 2015; 34: 565–571.
Kamudoni P, Maleta K, Shi Z, et al. Exclusive breastfeeding duration during the first 6 months of life is positively associated with length-for-age among infants 6–12 months old, in Mangochi district, Malawi. Eur J Clin Nutr. 2015; 69: 96–101.
Munthali T, Jacobs C, Sitali L, et al. Mortality and morbidity patterns in under-five children with severe acute malnutrition (SAM) in Zambia: a five-year retrospective review of hospital-based records (2009–2013). Arch Public Health. 2015; 73: 1–9.
Abdullah A. The double burden of undernutrition and overnutrition in developing countries: an update. Curr Obes Rep. 2015; 4: 337–349.
Schuetz P, Fehr R, Baechli V, et al. Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial. Lancet. 2019; 393: 2312–2321.
Arabi YM, Aldawood AS, Al-Dorzi HM, et al. Permissive underfeeding or standard enteral feeding in high- and low-nutritional-risk critically ill adults. Post hoc analysis of the PermiT trial. Am J Respir Crit Care Med. 2017; 195: 652–662.
Arabi YM, Aldawood AS, Haddad SH, et al. Permissive underfeeding or standard enteral feeding in critically ill adults. N Engl J Med. 2015; 372: 2398–2408.
Rice TW, Wheeler AP, Thompson BT, et al. Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial. JAMA. 2012; 307: 795–803.
Bally MR, Blaser Yildirim PZ, Bounoure L, et al. Nutritional support and outcomes in malnourished medical inpatients: a systematic review and meta-analysis. JAMA Intern Med. 2016; 176: 43–53.
Harvey SE, Parrott F, Harrison DA, et al. Trial of the route of early nutritional support in critically ill adults. N Engl J Med. 2014; 371: 1673–1684.
Lewis SR, Schofield-Robinson OJ, Alderson P, et al. Enteral versus parenteral nutrition and enteral versus a combination of enteral and parenteral nutrition for adults in the intensive care unit. Cochrane Database Syst Rev. 2018; 6: CD012276.
Casaer MP, Mesotten D, Hermans G, et al. Early versus late parenteral nutrition in critically ill adults. N Engl J Med. 2011; 365: 506–517.
Jayanama K, Theou O, Blodgett JM, et al. Frailty, nutrition-related parameters, and mortality across the adult age spectrum. BMC Med. 2018; 16: 1–23.
Guyonnet S, Rolland Y. Screening for malnutrition in older people. Clin Geriatr Med. 2015; 31: 429–437.
Rabito EI, Marcadenti A, da Silva Fink J, et al. Nutritional Risk Screening 2002, Short Nutritional Assessment Questionnaire, Malnutrition Screening Tool, and Malnutrition Universal Screening Tool are good predictors of nutrition risk in an emergency service. Nutr Clin Pract. 2017; 32: 526–532.
Kirkland LL, Shaughnessy E. Recognition and prevention of nosocomial malnutrition: a review and a call to action! Am J Med. 2017; 130: 1345–1350.
Gomes F, Schuetz P, Bounoure L, et al. ESPEN guidelines on nutritional support for polymorbid internal medicine patients. Clin Nutr. 2018; 37: 336–353.
McClave SA, Taylor BE, Martindale RG, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2016; 40: 159–211.
Schorghuber M, Fruhwald S. Effects of enteral nutrition on gastrointestinal function in patients who are critically ill. Lancet Gastroenterol Hepatol. 2018; 3: 281–287.
Pash E. Enteral nutrition: options for short-term access. Nutr Clin Pract. 2018; 33: 170–176.
Berger MM, Pichard C. Parenteral nutrition in the ICU: lessons learned over the past few years. Nutrition. 2018; 59: 188–194.
Cai W, Calder PC, Cury-Boaventura MF, et al. Biological and clinical aspects of an olive oil-based lipid emulsion — a review. Nutrients. 2018; 1–35.
Jones CJ, Calder PC. Influence of different intravenous lipid emulsions on fatty acid status and laboratory and clinical outcomes in adult patients receiving home parenteral nutrition: a systematic review. Clin Nutr. 2018; 37: 285–291.
Lappas BM, Patel D, Kumpf V, et al. Parenteral nutrition: indications, access, and complications. Gastroenterol Clin North Am. 2018; 47: 39–59.
Friedli N, Stanga Z, Sobotka L, et al. Revisiting the refeeding syndrome: results of a systematic review. Nutrition. 2017; 35: 151–160.
Dibb M, Lal S. Monitoring long-term parenteral nutrition. Curr Opin Gastroenterol. 2019; 35: 119–125.
Higuchi T, Abe M, Yamazaki T, et al. Levocarnitine improves cardiac function in hemodialysis patients with left ventricular hypertrophy: a randomized controlled trial. Am J Kidney Dis. 2016; 67: 260–270.
Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013; 309: 2005–2015.
Clarke R, Halsey J, Lewington S, et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37,485 individuals. Arch Intern Med. 2010; 170: 1622–1631.
Fortmann S, Burda B, Senger C, et al. Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013; 159: 824–834.
Lamas G, Roineau R, Goertz C, et al. Oral high-dose multivitamins and minerals after myocardial infarction: a randomized trial. Ann Intern Med. 2013; 159: 797–805.
Klein EA, Thompson IM Jr, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2011; 306: 1549–1556.
Bolland MJ, Grey A, Avenell A. Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis. Lancet Diabetes Endocrinol. 2018; 6: 847–858.
Manson JE, Cook N, Lee I-M, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. New Engl J Med. 2019; 380: 33–44.
Vitamin supplementation in pregnancy. Drug Ther Bull. 2016; 54: 81–84.
Viswanathan M, Treiman KA, Kish-Doto J, et al. Folic acid supplementation for the prevention of neural tube defects: an updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2017; 317: 190–203.
Manson JE, Bassuk SS. Vitamin and mineral supplements: what clinicians need to know. JAMA. 2018; 319: 859–860.
Green R. Vitamin B12 deficiency from the perspective of a practicing hematologist. Blood. 2017; 129: 2603–2611.
Garg A, Sharma A, Krishnamoorthy P, et al. Role of niacin in current clinical practice: a systematic review. Am J Med. 2017; 130: 173–187.
Mason JB, Tang SY. Folate status and colorectal cancer risk: a 2016 update. Mol Aspects Med. 2017; 53: 73–79.
Shipton MJ, Thachil J. Vitamin B12 deficiency—a 21st century perspective. Clin Med (Lond). 2015; 15: 145–150.
Nehra AK, Alexander JA, Loftus CG, et al. Proton pump inhibitors: review of emerging concerns. Mayo Clin Proc. 2018; 93: 240–246.
Kantor ED, Rehm CD, Du M, et al. Trends in dietary supplement use among US adults from 1999–2012. JAMA. 2016; 316: 1464–1474.
Lock J, Le Grange D, Agras WS, et al. Randomized clinical trial comparing family-based treatment with adolescent-focused individual therapy for adolescents with anorexia nervosa. Arch Gen Psychiatry. 2010; 67: 1025–1032.
Lipsman N, Lam E, Volpini M, et al. Deep brain stimulation of the subcallosal cingulate for treatment-refractory anorexia nervosa: 1 year follow up of an open-label trial. Lancet Psychiatry. 2017; 4: 285–294.
Poulsen S, Lunn S, Daniel SI, et al. A randomized controlled trial of psychoanalytic psychotherapy or cognitive-behavioral therapy for bulimia nervosa. Am J Psychiatry. 2014; 171: 109–116.
de Zwaan M, Herpertz S, Zipfel S, et al. Effect of internet-based guided self-help vs individual face-to-face treatment on full or subsyndromal binge eating disorder in overweight or obese patients: the INTERBED randomized clinical trial. JAMA Psychiatry. 2017; 74: 987–995.
Hudson JI, McElroy SL, Ferreira-Cornwell MC, et al. Efficacy of lisdexamfetamine in adults with moderate to severe binge-eating disorder: a randomized clinical trial. JAMA Psychiatry. 2017; 74: 903–910.
Walsh BT. Diagnostic categories for eating disorders: current status and what lies ahead. Psychiatr Clin North Am. 2019; 42: 1–10.
Hilbert A. Binge-eating disorder. Psychiatr Clin North Am. 2019; 42: 33–43.
Bailer UF, Price JC, Meltzer CC, et al. Dopaminergic activity and altered reward modulation in anorexia nervosa—insight from multimodal imaging. Int J Eat Disord. 2017; 50: 593–596.
Glenny EM, Bulik-Sullivan EC, Tang Q, et al. Eating disorders and the intestinal microbiota: mechanisms of energy homeostasis and behavioral influence. Curr Psychiatry Rep. 2017; 19: 1–9.
Steinhausen HC, Jakobsen H, Helenius D, et al. A nation-wide study of the family aggregation and risk factors in anorexia nervosa over three generations. Int J Eat Disord. 2015; 48: 1–8.
Westmoreland P, Krantz MJ, Mehler PS. Medical complications of anorexia nervosa and bulimia. Am J Med. 2016; 129: 30–37.
Kan C, Treasure J. Recent research and personalized treatment of anorexia nervosa. Psychiatr Clin North Am. 2019; 42: 11–19.
Resmark G, Herpertz S, Herpertz-Dahlmann B, et al. Treatment of anorexia nervosa—new evidence-based guidelines. J Clin Med. 2019; 8: 1–16.
Hay PJ, Touyz S, Claudino AM, et al. Inpatient versus outpatient care, partial hospitalisation and waiting list for people with eating disorders. Cochrane Database Syst Rev. 2019; 1: CD010827.
Lutter M. Emerging treatments in eating disorders. Neurotherapeutics. 2017; 14: 614–622.
Wade TD. Recent research on bulimia nervosa. Psychiatr Clin North Am. 2019; 42: 21–32.
McElroy SL, Guerdjikova AI, Mori N, et al. Psychopharmacologic treatment of eating disorders: emerging findings. Curr Psychiatry Rep. 2015; 17: 1–7.
Le LK, Barendregt JJ, Hay P, et al. Prevention of eating disorders: a systematic review and meta-analysis. Clin Psychol Rev. 2017; 53: 46–58.
Fichter MM, Quadflieg N, Crosby RD, et al. Long-term outcome of anorexia nervosa: results from a large clinical longitudinal study. Int J Eat Disord. 2017; 50: 1018–1030.
Khalsa SS, Portnoff LC, McCurdy-McKinnon D, et al. What happens after treatment? A systematic review of relapse, remission, and recovery in anorexia nervosa. J Eat Disord. 2017; 5: 1–12.
LeBlanc ES, Patnode CD, Webber EM, et al. Behavioral and pharmacotherapy weight loss interventions to prevent obesity-related morbidity and mortality in adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2018; 320: 1172–1191.
Espeland MA, Glick HA, Bertoni A, et al. Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes. Diabetes Care. 2014; 37: 2548–2556.
Gardner CD, Trepanowski JF, Del Gobbo LC, et al. Effect of low-fat vs low-carbohydrate diet on 12-month weight loss in overweight adults and the association with genotype pattern or insulin secretion: the DIETFITS Randomized Clinical Trial. JAMA. 2018; 319: 667–679.
Johnston BC, Kanters S, Bandayrel K, et al. Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. JAMA. 2014; 312: 923–933.
Schwingshackl L, Dias S, Hoffmann G. Impact of long-term lifestyle programmes on weight loss and cardiovascular risk factors in overweight/obese participants: a systematic review and network metaanalysis. Syst Rev. 2014; 3: 130.
Villareal DT, Aguirre L, Gurney AB, et al. Aerobic or resistance exercise, or both, in dieting obese older adults. N Engl J Med. 2017; 376: 1943–1955.
Khera R, Murad MH, Chandar AK, et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA. 2016; 315: 2424–2434.
Garvey WT, Ryan DH, Look M, et al. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr. 2012; 95: 297–308.
Smith SR, Weissman NJ, Anderson CM, et al. Behavioral Modification and Lorcaserin for Overweight and Obesity Management (BLOOM) Study Group. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med. 2010; 363: 245–256.
Bohula EA, Wiviott SD, McGuire DK, et al. Cardiovascular safety of lorcaserin in overweight or obese patients. N Engl J Med. 2018; 379: 1107–1117.
Nissen SE, Wolski KE, Prcela L, et al. Effect of naltrexone-bupropion on major adverse cardiovascular events in overweight and obese patients with cardiovascular risk factors: a randomized clinical trial. JAMA. 2016; 315: 990–1004.
Pi-Sunyer X, Astrup A, Fujioka K, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015; 373: 11–22.
Jakobsen GS, Smastuen MC, Sandbu R, et al. Association of bariatric surgery vs medical obesity treatment with long-term medical complications and obesity-related comorbidities. JAMA. 2018; 319: 291–301.
Adams TD, Davidson LE, Litwin SE, et al. Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med. 2017; 377: 1143–1155.
Peterli R, W?lnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018; 319: 255–265.
Salminen P, Helmi? M, Ovaska J, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA. 2018; 319: 241–254.
GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017; 377: 13–27.
Ogden CL, Fryar CD, Hales CM, et al. Differences in obesity prevalence by demographics and urbanization in US children and adolescents, 2013–2016. JAMA. 2018; 319: 2410–2418.
Hales CM, Fryar CD, Carroll MD, et al. Differences in obesity prevalence by demographic characteristics and urbanization level among adults in the United States, 2013–2016. JAMA. 2018; 319: 2419–2429.
Johnson W, Li L, Kuh D, et al. How has the age-related process of overweight or obesity development changed over time? Co-ordinated analyses of individual participant data from five United Kingdom birth cohorts. PLoS Med. 2015; 12: 1–20.
Bierregaard LG, Jensen BW, ?ngquist L, et al. Change in overweight from childhood to early adulthood and risk of type 2 diabetes. N Engl J Med. 2018; 378: 1302–1312.
Aune D, Sen A, Prasad M, et al. BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3.74 million deaths among 30.3 million participants. BMJ. 2016; 353: 1–17.
Afzal S, Tybjaerg-Hansen A, Jensen GB, et al. Change in body mass index associated with lowest mortality in Denmark, 1976–2013. JAMA. 2016; 315: 1989–1996.
Oussaada SM, van Galen KA, Cooiman MI, et al. The pathogenesis of obesity. Metabolism. 2019; 92: 26–36.
Foucan L, Larifla L, Durand E, et al. High prevalence of rare monogenic forms of obesity in obese Guadeloupean Afro-Caribbean children. J Clin Endocrinol Metab. 2018; 103: 539–545.
Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017; 376: 254–266.
Francisco V, Pino J, Campos-Cabaleiro V, et al. Obesity, fat mass and immune system: role of leptin. Front Physiol. 2018; 9: 1–20.
Matafome P, Eickhoff H, Letra L, Sei?a R. Neuroendocrinology of adipose tissue and gut-brain axis. Adv Neurobiol. 2017; 19: 49–70.
Ruiz JR, Martinez-Tellez B, Sanchez-Delgado G, et al. Role of human brown fat in obesity, metabolism and cardiovascular disease: strategies to turn up the heat. Prog Cardiovasc Dis. 2018; 61: 232–245.
Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body fatness and cancer—viewpoint of the IARC Working Group. N Engl J Med. 2016; 375: 794–798.
Diehl AM, Day C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med. 2017; 377: 2063–2072.
Curry SJ, Krist AH, Owens DK, et al. Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force recommendation statement. JAMA. 2018; 320: 1163–1171.
Bray GA, Fruhbeck G, Ryan DH, et al. Management of obesity. Lancet. 2016; 387: 1947–1956.
Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016; 22 suppl 3: 1–203.
Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2015; 100: 342–362.
Andrew CA, Saunders KH, Shukla AP, et al. Treating obesity in patients with cardiovascular disease: the pharmacotherapeutic options. Expert Opin Pharmacother. 2019; 20: 585–593.
Adams TD, Davidson LE, Litwin SE, et al. Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med. 2017; 377: 1143–1155.
